Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Effect of brain-derived neurotrophic factor on activity-regulated cytoskeleton-associated protein gene expression in primary frontal cortical neurons. Comparison with NMDA and AMPA

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Radiosynthesis and in vitro validation of (3)H-NS14492 as a novel high affinity alpha7 nicotinic receptor radioligand

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The impact of legislation on drug substances used off-label in paediatric wards--a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Axonal voltage-gated ion channels as pharmacological targets for pain

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. DNA methylation regulates CHRNA7 transcription and can be modulated by valproate

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The effect of brain-derived neurotrophic factor (BDNF) on activity-regulated cytoskeleton-associated protein (Arc) mRNA levels in primary neuronal cultures of rat frontal cortex was characterized pharmacologically and compared to the effect on expression of c-fos, bdnf, neuritin, cox-2 as examples of other immediate early genes. BDNF induced a very strong increase (around 100 fold) in Arc mRNA and the maximal effect seen at 25 ng/ml. The effect was dose-dependent with EC50 around 1.6 ng/ml. The time profile revealed a significant effect after 25 min. BDNF also increased levels of c-Fos, neuritin and BDNF mRNA, but not COX-2 mRNA. The pharmacological profile of NMDA and AMPA-induced arc gene expression in frontal cortical neurons was compared to BDNF. NMDA and AMPA increased Arc mRNA but their maximal effect did not exceed 20-fold. The effect of AMPA was completely blocked by the NMDA receptor antagonist MK-801. Further, the relative amount of Arc mRNA compared to c-Fos mRNA was higher for BDNF, equal for NMDA and lower for AMPA. These results demonstrate BDNF to be a highly potent and efficient inducer of arc gene expression in vitro, emphasizing the role of this growth factor in synaptic plasticity in the frontal cortex.
Original languageEnglish
JournalEuropean Journal of Clinical Pharmacology
Volume660
Issue number2-3
Pages (from-to)351-7
Number of pages7
ISSN0031-6970
DOIs
Publication statusPublished - 2011

    Research areas

  • Animals, Brain-Derived Neurotrophic Factor, Cytoskeletal Proteins, Dose-Response Relationship, Drug, Female, Frontal Lobe, Gene Expression Regulation, Humans, N-Methylaspartate, Nerve Tissue Proteins, Neurons, Pregnancy, Proto-Oncogene Proteins c-fos, RNA, Messenger, Rats, Rats, Sprague-Dawley, Receptors, AMPA, Receptors, N-Methyl-D-Aspartate, Time, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid

ID: 33171034